Indian markets stall on inflation fears as traders target pharma and sugar
Persistent market sluggishness and regulatory uncertainty in the banking sector are keeping Indian indices range-bound, driving investors toward selective opportunities in pharmaceuticals, financial services, and sugar production.
Indian equities closed mixed on Monday as elevated crude oil prices and regulatory concerns capped broader gains. The benchmark Nifty 50 index declined by 0.12 percent to settle at 24,366.40, whereas the Sensex managed a marginal 0.18 percent gain to reach 78,220.15.
Lenders and financial services firms lost approximately 0.4 percent as market participants digested the Reserve Bank of India’s proposed loan-pricing guidelines. Smaller companies fared better, with mid-cap and small-cap indices rising 0.3 percent and 0.4 percent, respectively, while Tata Motors surged 3.5 percent on robust quarterly demand.
As ten out of sixteen industry groups finished lower, overall market momentum stalled alongside crude oil prices hovering near $88 per barrel. Technical indicators point to a range-bound setup, with the Nifty facing resistance near 23,500 and a maximum pain point at 23,300.
This hesitant environment has prompted analysts to recommend a highly selective approach for Tuesday's trading session. NeoTrader co-founder Raja Venkatraman identified three stocks for multiday trades, focusing on companies showing technical breakouts despite broader market stagnation.
Venkatraman recommends buying Ipca Laboratories above ₹1,890 with a target of ₹2,150 and a stop loss at ₹1,790. The pharmaceutical multinational, trading at a price-to-earnings ratio of 38.42, is showing upward momentum following strong first-quarter earnings and a broader sector revival.
He notes that investors should be aware of risks including regulatory compliance challenges and supply chain disruptions. The stock recorded a trading volume of 6.96 million shares, approaching its 52-week high of ₹1,941.40.
For the financial sector, Venkatraman suggests buying Motilal Oswal Financial Services above ₹960, targeting ₹1,060 with a stop at ₹910. The firm's stock, carrying a P/E of 54.56, is displaying a rounding pattern breakout that indicates muted quarterly results are fully priced in.
Finally, he recommends entering Balrampur Chini Mills above ₹658, aiming for ₹725 with a stop loss at ₹625. The integrated sugar producer, with a P/E of 40.44, is making a steady recovery after the market absorbed weaker first-quarter results.
Investors in the sugar stock should monitor risks related to cane pricing structures, ethanol allocations, and potential global supply gluts. The stock saw 1.4 million shares change hands, trading near its 52-week high of ₹664.80.
